Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: Nanobody-based CAR-T cells for cancer immunotherapy

Fig. 2

An illustration of a human and a llama immunoglobulin G and their applicable derivatives as CAR targeting domains. CH1, heavy chain constant domain 1; CH2, heavy chain constant domain 2; CH3, heavy chain constant domain 3; CL, light chain constant domain; IgG, immunoglobulin G; VH, heavy chain variable domain; VHH, single variable domain on a heavy chain; VL, light chain variable domain

Back to article page